What are the real long-term heart risks of TRT?

For years, cardiovascular risk was the default concern attached to testosterone therapy. The worry made intuitive sense: testosterone affects red blood cell production, blood pressure, and lipid profiles — all variables that touch the heart. Caution seemed reasonable.

But caution based on incomplete evidence is still incomplete. The science has moved significantly, and men making decisions about their health deserve to know where it stands.

What the TRAVERSE Trial found.

The TRAVERSE Trial — one of the largest and most rigorous studies ever conducted on testosterone therapy — published its findings and reached a clear conclusion: for hypogonadal men whose levels are managed appropriately, TRT does not increase the risk of major adverse cardiac events. No statistically significant increase in heart attack. No increase in stroke. The myth that managed testosterone therapy is inherently dangerous to the heart has been directly contradicted by the best available evidence.

Managed testosterone, restored to physiological levels, is not a cardiac risk factor. Unmanaged low testosterone, however, is associated with metabolic syndrome, insulin resistance, and increased cardiovascular burden.

What we actually monitor.

At Pure Metabolics, cardiovascular safety is built into every care plan from day one. The markers we track at each lab cycle:

• Hematocrit and Hemoglobin: The primary blood-viscosity markers. Elevated Hematocrit increases the workload on the heart. We act before it becomes a problem.
• Lipid panel (LDL, APOB): TRT can influence cholesterol. We track the trend, not just the snapshot.
• Blood pressure: We ask patients to log readings at home between visits. Small changes in blood pressure are meaningful over time.

If any marker suggests a need for specialist co-management, we make that referral. The goal is not to be the only clinician in your life — it is to be the one who is paying attention.

The honest picture.

TRT is not risk-free. No medical intervention is. But the risks of optimized, monitored testosterone therapy are well understood and manageable. The risks of leaving low testosterone unaddressed — metabolic deterioration, cardiovascular strain from visceral fat accumulation, insulin resistance — are also real, and often go unacknowledged in the same breath.

You deserve both sides of that conversation.

Disclaimer: TRT should only be initiated after thorough health screening. If you have a history of heart disease, clearance from your cardiologist is required before starting therapy.